Xvivo Perfusion Aktiebolag earnings
Annual earnings per share (SEK per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2023 | 2023-12-31 | SEK 3.07 | SEK 3.07 | 2026-06-19T06:13:00Z |
| 2022 | 2022-12-31 | SEK 0.62 | SEK 0.62 | 2026-06-19T06:13:00Z |
Revenue & profit (SEK)
| Concept | 2023 | 2022 |
|---|---|---|
| Revenue | SEK 597.5M | SEK 415.3M |
| Profit for the year | SEK 91.8M | SEK 18.4M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in Xvivo Perfusion Aktiebolag's ESEF annual reports (source:
filings.xbrl.org).
Figures are in SEK, as reported. Not investment advice.